Impact BioMedical, Inc.
Market Cap
47M
Short interest (Jul 15)
0.5%
Net Short (Jul 27 ): 0.0%
Borrow Fee
10.10%
↓ 11.6%
Available Shares
1M
↑ 62.6%
Price Chart
Company Overview
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.